Modifying national malaria treatment policies in Peru

Journal of Public Health Policy

Volumn 25, Issue 3-4, 2004, Pages 328-345

  Ruebush II, Trenton K ^a   Neyra, Daniel ^a   Cabezas, César ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; FANSIDAR; MEFLOQUINE; PRIMAQUINE; QUININE; TETRACYCLINE;

DRUG CHOICE; DRUG COST; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MALARIA; MEDICAL DECISION MAKING; PERU; PLASMODIUM FALCIPARUM; REVIEW; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION;

ANTIMALARIALS; DEVELOPING COUNTRIES; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HEALTH POLICY; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; PERU;

EID: 10944269270     PISSN: 01975897     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jphp.3190032     Document Type: Review

References (36)

1. World Health Organization. A global strategy for malaria control, Geneva, 1993.
2. World Health Organization. Chemotherapy of malaria and resistance to antimalarials: report of a WHO Scientific Group, Technical Report Series No. 529, Geneva, 1973.
3. Plowe, C.V., Kublin, J.G., Doumbo, O.K. P. falciparum DHFR and DHPS mutations: epidemiology and role in clinical resistance to antifolates, Drug Resist. Updates, 1 (1998): 1-8.
4. Fidock, D.A., Nomura, T., Talley, A.K., Cooper, R.A., Dzekunov, S.M., Ferdig, M.T., Ursos, L.M., bir Singh Sidhu, A., Naude, B., Deitsch, K.W., Su, X., Wootton, J.C., Roepe, P.D. and Wellems, T.E. Mutations in the P. falciparum digestive vacuole transmembrane protein pfcrt and evidence for their role in chloroquine resistance, Molecular Cell 6 (2000): 861-71.
5. Reed, M.B., Saliba, K.J., Caruana, S.R., Kirk, K., and Cowman, A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum, Nature 403 (2000): 906-09.
6. World Health Organization. The use of artemisinin and its derivatives as anti-malarial drugs: report of a joint CTD/DMP/TDR informal consultation. WHO Document WHO/MAL/98.1086, Geneva, 1998.
7. White, N.J. Preventing antimalarial drug resistance through combinations, Drug Resist. Updates 1 (1998): 3-9.
8. Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K.L., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., and White, N.J. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study, Lancet 356 (2000): 297-302.
9. Price, R.N., Nosten, F., Luxemburger, C., ter Kuile, F.O., Paiphun, L., Chongsuphajaisiddhi, T., and White, N.J. Effects of artemisinin derivatives on malaria transmissability, Lancet 347 (1996): 1654-58.
10. World Health Organization. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. WHO Document No. WHO/MAL/96.1077. Geneva, 1996.
11. Pan American Health Organization. Evaluation of the therapeutic efficacy of drugs for the treatment of uncomplicated Plasmodium falciparum malaria in the Americas, OPS/HCP/HCT/113/98. Washington D.C., 1998.
12. Fernandez, R., Carbajal, F., Quintana, J., Chauca, H., and Watts, D.M. Presencia del A. (N) darlingi (Diptera: Culicidae) en alrededores de la ciudad de Iquitos, Loreto-Peru, Soc. Peruana Enferm. Inf. Trop. 5 (1996): 10-12.
13. Aramburú-Guarda, J., Ramal-Asayag, C., and Witzig, R. Malaria reemergence in the Peruvian Amazon region, Emerg. Inf. Dis. 5 (1999): 209-15.
14. Colán E., Quintana, J., Ferreli, R., San Roman, E., and Rios, R. Malaria por Plasmodium falciparum en la Amazonia Peruana, Rev. Farmacol. Terap. (Lima) 3 (1993): 11-16.
15. Chauca H. and Quintana J. Evaluación in vivo de la respuesta de Plasmodium falciparum a la cloroquina en el foco carretera Yurimaguas-Tarapoto (Región Loreto), Ref. Peruana Epidem. 6 (1993): 34-39.
16. Ruebush, T.K. II, Levin, A., Gonzaga, V., Neyra, D., and Marquiño, W. Evaluation of a simple operational approach for monitoring resistance to antimalarial drugs in Peru, Trop. Med. Int. Health (in press).
17. Roper, M.H., Torres, R.S., Goicochea, C.G., Andersen, E.M., Guarda, J.S., Calampa, C., Hightower, A.W., and Magill, A.J. The epidemiology of malaria in an epidemic area of the Peruvian Amazon, Am. J. Trop. Med. Hyg. 62 (2000): 247-56.
18. Ruebush, T.K. II, Zeissig, R., Klein, R.E., and Godoy, H.A. Community participation in malaria surveillance and treatment. II. Evaluation of the Volunteer Collaborator Network of Guatemala, Am. J. Trop. Med. Hyg. 46 (1992): 261-71.
19. Kroeger, A., Meyer, R., Mancheno, M., and González, M. Health education for community-based malaria control: an intervention study in Ecuador, Colombia, and Nicaragua, Trop. Med. Int. Health 1 (1996): 836-46.
20. Marquiño, W., MacArthur, J.R., Barat, L.M., Oblitas, F.E., Arrunátegui, M., Garavito, G., Chafloque, M.L., Pardavé, B., Gutierrez, S., Arróspide, N., Carrillo, C., Cabezas, C., and Ruebush, T.K. II. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru, Am. J. Trop. Med. Hyg. 68 (2003): 120-23.
21. Marquiño, W., Huilca, M., Calampa, C., Falconí, E., Cabezas, C., Naupay, R., and Ruebush, T.K. II. Efficacy of mefloquine and mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru, Am. J. Trop. Med. Hyg. 68 (2003): 608-612.
22. Phillips, E.J., Keystone, J.S., and Kain, K.C.. Failure of combined chloroquine and high dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America, Clin. Infect. Dis. 23 (1996): 1171-73.
23. Alecrim, M.C., Alecrim, W. and Macedo, V. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian amazon Region, Rev. Soc. Bras. Med. Trop. 32 (1999): 67-68.
24. Ruebush T.K. II, Zegarra J., Cairo J., Andersen E.M., Green M., Pillai D., Marquiño W., Huilca M., Arévalo E., Garcia C., Solary L., Kain, K.C. Chloroquine-resistant Plasmodium vivax malaria in Peru, Am. J. Trop. Med. Hyg. (in press).
25. Moore, D.V., and Lanier, J.E. Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine, Am. J. Trop. Med. Hyg. 10 (1961): 5-9.
26. Bloland, P.B., amd Ettling, M. Making malaria-treatment policy in the face of drug resistance, Ann. Trop. Med. Parasitol. 93 (1999): 5-23.
27. Bloland, P.B., Kazembe, P.N., Oloo, A.J., Himonga, B., Barat, L.M., and Ruebush, T.K. Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa, Trop. Med. Int. Health 3 (1998): 543-52.
28. White, N.J. Antimalarial drug resistance: the pace quickens, J. Antimicrob. Chemother. 30 (1992): 571-85.
29. Barat, L.M., Himonga, B., Nkunika, S., Ettling, M., Ruebush, T.K., Kapelwa, W., and Bloland, P.B. A systematic approach to the development of a rational malaria treatment policy in Zambia, Trop. Med. Int. Health 3 (1998): 535-42.
30. Bloland, P.B., Lackritz, E.M., Kazembe, P.N., Were, J.B.O., Steketee, R., and Campbell, C.C. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa, J. Infect. Dis. 167 (1993): 932-37.
31. Trape, J.F., Pison, G., Preziosi, M.P., Enel, C., Desgrées du Loû, A., Delaunay, V., Samb B., Lagarde, E., Molez, J.F., and Simondon, F. Impact of chloroquine resistance on malaria mortality, Acad. Sci. Paris, Sciences de la Vie 321 (1998): 689-97.
32. Zucker, J.R., Lackritz, E.M., Ruebush, T.K. II, Hightower, A.W., Adungosi, J.E., Were, J.B., Metchock, B., Patrick, E., and Cambpell, C.C. Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens, Am. J. Trop. Med. Hyg. 55 (1996): 655-60.
33. Kamya, M.R., Bakyaita, N.N., Talisuna, A.O., Were, W.M., and Staedke, S.G. Increasing antimalarial drug resistance in Uganda and revision of the national drug policy, Trop. Med. Int. Health 7 (2002): 1031-41.
34. Shretta, R., Omumbo, J., Rapuoda, B., and Snow, R.W. Using evidence to change antimalarial drug policy in Kenya, Trop. Med. Int. Health 5 (2000): 755-64.
35. Fèvre, E.M., Barnish, G. Malaria-treatment policies: when and how should they be changed? Ann. Trop. Med. Parasitol. 93 (1999): 549-560.
36. Tarimo, D.S., Minjas, J.N., Bygbjerg, I.C. Perception of chloroquine efficacy and alternative treatments for uncomplicated malaria in children in a holoendemic area of Tanzania: implications for the change of treatment policy. Trop. Med. Int. Health 6 (2001): 992-997.